INDUCTION OF APOPTOSIS IN B16 MELANOMA CELLS UNDER THE ACTION OF DRUG CONTAINING TUMOR NECROSIS FACTOR ALPHA AS A PART OF VIRUS-LIKE PARTICLES <em>IN VITRO</em>-Reference-Cited by-同舟云学术

INDUCTION OF APOPTOSIS IN B16 MELANOMA CELLS UNDER THE ACTION OF DRUG CONTAINING TUMOR NECROSIS FACTOR ALPHA AS A PART OF VIRUS-LIKE PARTICLES IN VITRO

Published:2020-09-02 Issue:4 Volume:19 Page:99-104
ISSN:2312-3168
Container-title:Siberian journal of oncology
language:
Short-container-title:Sib. onkol. ž.

Author:

Vyazovaya E. A.¹,Lebedev L. R.¹,Danilenko E. D.¹^ORCID

Affiliation:

1. Institute of Medical Biotechnology, State Research Center of Virology and Biotechnology «Vector»

Publisher

Tomsk Cancer Research Institute

Subject

Cancer Research,Oncology

Reference18 articles.

1. Bernardo A.R., Cosgaya J.M., Aranda A., Jiménez-Lara A.M. Synergy between RA and TLR3 promotes type I IFN-dependent apoptosis through upregulation of TRAIL pathway in breast cancer cells. Cell Death Dis. 2013 Jan 31; 4: e479. doi: 10.1038/cddis.2013.5.

2. Ketlinsky S.A., Simbirtsev A.S. Cytokines. Saint Peterburg, 2008. 552 p. (in Russian).

3. Lienard D., Ewalenko P., Delmotte J.J., Renard N., Lejeune F.J. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol. 1992 Jan; 10(1): 52–60. doi: 10.1200/JCO.1992.10.1.52.

4. Chubenko V.A. Immunotherapy is based on cytokines (IL-1, IL-2, FNO, CSF, IFN). Practical Oncology. 2016; 17(2): 99–109. (in Russian). doi: 10.31917/1702099.

5. Xu G., Gu H., Hu B., Tong F., Liu D., Yu X., Zheng Y., Gu J. PEGb-(PELG-g-PLL) nanoparticles as TNF-α nanocarriers: potential cerebral ischemia/reperfusion injury therapeutic applications. Int J Nanomedicine. 2017 Mar 23; 12: 2243–2254. doi: 10.2147/IJN.S130842.